We are live on
!
Find out more
CAN
Claraphi Advisory Network Portfolio holdings
AUM
$251M
Turnover
51.06%
1-Year Est. Return
9.29%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
-9.29%
3 Year Est. Return
+88.33%
5 Year Est. Return
+135.31%
10 Year Est. Return
–
AUM
$155M
AUM Growth
+$13.9M
(+9.8%)
Cap. Flow
+$9.72M
Cap. Flow
% of AUM
6.27%
Top 10 Holdings %
Top 10 Hldgs %
23.12%
Holding
295
New
39
Increased
101
Reduced
106
Closed
28
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$10.3M |
| 2 |
ARK Innovation ETF
ARKK
|
+$2.16M |
| 3 |
Alerian MLP ETF
AMLP
|
+$1.09M |
| 4 |
BlackRock Resources & Commodities Strategy Trust
BCX
|
+$756K |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$540K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
abrdn Life Sciences Investors
HQL
|
+$2.64M |
| 2 |
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$1.94M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$553K |
| 4 |
Invesco Financial Preferred ETF
PGF
|
+$551K |
| 5 |
Meta Platforms (Facebook)
META
|
+$482K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.15% |
| 2 | Technology | 11.9% |
| 3 | Healthcare | 7.01% |
| 4 | Financials | 5.78% |
| 5 | Consumer Discretionary | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
First Trust Value Line Dividend Fund
FVD
$7.83B
| $536K | 0.35% |
17,697
+61
| +0.3% | +$1.83K |
2017 Q4
2 quarters
|
|
77
Align Technology
ALGN
$10.6B
| $533K | 0.34% |
1,559
+90
| +6% | +$26.8K |
2017 Q4
2 quarters
|
|
78
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.91B
| $520K | 0.34% |
18,191
+81
| +0.4% | +$2.31K |
2017 Q4
2 quarters
|
|
79
iShares Select Dividend ETF
DVY
$23B
| $510K | 0.33% |
5,214
-25
| -0.5% | -$2.43K |
2017 Q4
2 quarters
|
|
80
iShares MSCI Japan ETF
EWJ
$23.2B
| $510K | 0.33% |
8,819
+906
| +11% | +$54.6K |
2017 Q4
2 quarters
|
|
81
Mastercard
MA
$540B
| $510K | 0.33% |
2,596
+17
| +0.7% | +$3.2K |
2017 Q4
2 quarters
|
|
82
State Street SPDR S&P International Dividend ETF
DWX
$519M
| $509K | 0.33% |
13,275
+400
| +3% | +$15.8K |
2018 Q1
1 quarter
|
|
83
Weibo
WB
$1.61B
| $492K | 0.32% |
5,542
-1,629
| -23% | -$177K |
2017 Q4
2 quarters
|
|
84
Arbor Realty Trust
ABR
$522M
| $491K | 0.32% |
+47,050
| New | +$438K |
2018 Q2
0 quarters
|
|
85
Ferrari
RACE
$69.9B
| $478K | 0.31% |
3,538
-375
| -10% | -$49.3K |
2017 Q4
2 quarters
|
|
86
Copart
CPRT
$25.7B
| $476K | 0.31% |
33,756
+2,416
| +8% | +$32.7K |
2018 Q1
1 quarter
|
|
87
Vanguard Morningstar Growth ETF
VUG
$232B
| $474K | 0.31% |
18,996
-690
| -4% | -$16.9K |
2017 Q4
2 quarters
|
|
88
Blackstone
BX
$87.1B
| $467K | 0.3% |
14,517
-100
| -0.7% | -$3.18K |
2017 Q4
2 quarters
|
|
89
Idexx Laboratories
IDXX
$43.1B
| $462K | 0.3% |
2,119
| – | – |
2017 Q4
2 quarters
|
|
90
GSK
GSK
$98.2B
| $452K | 0.29% |
8,970
+3,049
| +51% | +$154K |
2017 Q4
2 quarters
|
|
91
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.21B
| $452K | 0.29% |
9,389
-780
| -8% | -$36.8K |
2017 Q4
2 quarters
|
|
92
Vanguard Health Care ETF
VHT
$19.9B
| $450K | 0.29% |
2,832
| – | – |
2017 Q4
2 quarters
|
|
93
Mettler-Toledo International
MTD
$32.8B
| $445K | 0.29% |
770
-118
| -13% | -$67.3K |
2017 Q4
2 quarters
|
|
94
Vanguard Real Estate ETF
VNQ
$36.7B
| $443K | 0.29% |
5,439
+336
| +7% | +$26K |
2017 Q4
2 quarters
|
|
95
Vanguard Morningstar Value ETF
VTV
$190B
| $441K | 0.28% |
+4,248
| New | +$445K |
2018 Q2
0 quarters
|
|
96
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.52B
| $438K | 0.28% |
7,580
+134
| +2% | +$8.16K |
2017 Q4
2 quarters
|
|
97
State Street Materials Select Sector SPDR ETF
XLB
$7.99B
| $434K | 0.28% |
14,946
-11,038
| -42% | -$323K |
2017 Q4
2 quarters
|
|
98
Invesco Dorsey Wright Momentum ETF
PDP
$1.46B
| $433K | 0.28% |
7,824
-210
| -3% | -$11.5K |
2017 Q4
2 quarters
|
|
99
Citigroup
C
$207B
| $432K | 0.28% |
6,453
-224
| -3% | -$15.4K |
2017 Q4
2 quarters
|
|
100
Raymond James Financial
RJF
$30.3B
| $413K | 0.27% |
6,935
+237
| +4% | +$14.7K |
2017 Q4
2 quarters
|
|
Similar funds
JW
A
APP
RW
SCM
ACMV
GTCM
CDIA
Claraphi Advisory Network's Q2 2018 Portfolio in Review
As of Q2 2018, Claraphi Advisory Network held 295 positions worth $155M, up 9.8% from $141M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Claraphi Advisory Network deployed $9.72M of net new capital in Q2 2018, opening 39 new positions and adding to 101 existing holdings. Its largest new stake was ARK Innovation ETF: 50,557 shares worth $2.27M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 45% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was abrdn Life Sciences Investors, an estimated $2.64M trimmed.
- Claraphi Advisory Network's largest Q2 2018 buy was ARK Innovation ETF: 50,557 shares worth $2.27M.
- Claraphi Advisory Network added most to State Street SPDR Bloomberg Convertible Securities ETF in Q2 2018, an estimated $10.3M increase.
- Claraphi Advisory Network's biggest Q2 2018 reduction was abrdn Life Sciences Investors, cutting an estimated $2.64M.
- Claraphi Advisory Network fully exited Deere & Co in Q2 2018, selling an estimated $373K.
- Claraphi Advisory Network's ten largest holdings make up 23% of its $155M portfolio in Q2 2018.
- Claraphi Advisory Network opened 39 new positions and closed 28 in Q2 2018.
- Claraphi Advisory Network's portfolio value rose 9.8% quarter-over-quarter to $155M.
Based on Claraphi Advisory Network's 13F filing for Q2 2018, filed 14 Aug 2018.